Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells. - Wikidata - wikimedia - TriplyDB

Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.

Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.

http://www.wikidata.org/entity/Q38335697

about

PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer ERG transcriptional networks in primary acute leukemia cells implicate a role for ERG in deregulated kinase signaling Alcohol-induced serotonergic modulation: the role of histone deacetylases Targeting the DNA-binding activity of the human ERG transcription factor using new heterocyclic dithiophene diamidines Chromatin remodeling, cell proliferation and cell death in valproic acid-treated HeLa cells Oncogenic activation of ERG: A predominant mechanism in prostate cancer.Defining the role of histone deacetylases in the inhibition of mammary carcinogenesis by dietary energy restriction (DER): effects of suberoylanilide hydroxamic acid (SAHA) and DER in a rat model.Autophagy is differentially induced in prostate cancer LNCaP, DU145 and PC-3 cells via distinct splicing profiles of ATG5.A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers.Histone deacetylases and mechanisms of regulation of gene expression Quantitative Measurement of Histone Tail Acetylation Reveals Stage-Specific Regulation and Response to Environmental Changes during Drosophila Development.Mechanisms of trichostatin A inhibiting AGS proliferation and identification of lysine-acetylated proteins Valproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma Trichostatin A Enhances the Apoptotic Potential of Palladium Nanoparticles in Human Cervical Cancer Cells.Androgen receptor and gene network: Micromechanics reassemble the signaling machinery of TMPRSS2-ERG positive prostate cancer cells.Ets Related Gene and Smad3 Proteins Collaborate to Activate Transforming Growth Factor-Beta Mediated Signaling Pathway in ETS Related Gene-Positive Prostate Cancer Cells.Molecular Mechanism of Activation of Transforming Growth Factor Beta/Smads Signaling Pathway in Ets Related Gene-Positive Prostate Cancers.Anti-Epileptic Drug Targets Ewing Sarcoma.Nephrotoxicity of epigenetic inhibitors used for the treatment of cancer.Molecular Mechanism of β-Catenin Signaling Pathway Inactivation in ETV1-Positive Prostate Cancers.Effect of Genistein in Comparison with Trichostatin A on Reactivation of DNMTs Genes in Hepatocellular Carcinoma.

P2860

Q26752933-A3E1CA9D-B64D-41B7-B246-B8C97E133538 Q28484833-1CFA1011-8FE7-4FAF-B2DD-AA2BDC6C0481 Q28727541-F2F99ECC-F8D0-4F3C-AD31-1BA2013F8972 Q28771722-CEA61D11-D485-4C58-967A-2CF6C5DC8CE0 Q34113695-45DD04C6-D377-41AE-A1BD-16B176660F3C Q35685920-B710EC64-BC78-451D-B062-F75BD6B42E6E Q36257402-20D7EABD-A3DF-4D06-98E7-25CB1B239B82 Q36524164-98DD5A8B-92B9-444A-865C-31CD2E205C94 Q36689831-2202AEAE-5FB0-4C9B-AD51-54D1AB1940DB Q36734390-4D90F275-A849-4B60-A68C-587F59B32A11 Q36765827-6683A884-9CD3-4F0C-990F-811069CFBFAA Q36897907-593C2C45-2D83-4FB4-8FAB-3E721D29E5B1 Q37009223-E82BD5A3-750F-498C-8619-999ABACD0ED8 Q37210234-E66A0A66-969B-4272-A414-1EB2C9F6F16C Q37727814-01D3CA7F-51BC-4ED4-BAE9-65E32BC52B85 Q38300608-B845C798-8ABE-41B1-B57C-1CC59A93E5CB Q38301071-44B092E5-7231-47FC-9CC1-C4408E797FFB Q38301170-76400461-B0F9-4068-82FF-2253495E0AAB Q38750965-1EFCCB7A-B94C-483B-B08E-0158E7E44DD7 Q41446090-18F9B750-4FF6-42A7-9E3A-FD29431F71F8 Q55419793-453867E8-10ED-4F2F-9FA0-C94F599FAD6A

P2860

Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.

http://www.wikidata.org/entity/Q38335697

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Histone deacetylase inhibitors ...... ositive prostate cancer cells.

@en

type

label

Histone deacetylase inhibitors ...... ositive prostate cancer cells.

@en

prefLabel

Histone deacetylase inhibitors ...... ositive prostate cancer cells.

@en

P1433

Q38335697-53E354A2-73A9-412F-AE4D-DC320BA58443

P1476

Q38335697-A35A3C60-3235-446D-98A4-1C0E16B9CF6B

P2093

Q38335697-06A6B493-20D0-4058-A570-7975F6D90118

Q38335697-2FA3C79A-2ED3-4F6F-B778-FBD69E9E6472

Q38335697-5C9EB812-F9D4-484C-A571-4E38E55E8EC1

Q38335697-78A449A4-A516-4711-98BA-F4AC44313AFE

Q38335697-8E5CCC6C-C658-4DDF-A1AA-664124308B81

Q38335697-AF177BD6-658E-41C5-A283-9EF2ECE380AB

Q38335697-CC0F3073-1CE4-4F38-BA8E-2575D52DE5CE

Q38335697-EF57D0DC-4D33-4B8C-BB09-E49D0A37B268

Q38335697-FB933CDC-649F-4862-B389-88B1375F6BAF

P2860

Q38335697-02D91888-0C2F-4A43-8C92-03579AEFFF50

Q38335697-03787D18-4D9E-4605-A418-C32F8794E0FB

Q38335697-040A6F88-4DF0-4D2B-9742-4B10839D1009

Q38335697-083587A6-30D5-41B7-850A-53A64BE0F57A

Q38335697-0ABC3AD4-C435-4CAB-8BCC-724EF744A9DF

Q38335697-13A71DFF-2E08-4536-9638-D35BF72CA63B

Q38335697-1440F557-C101-419F-A8FF-EDC1844C8B9E

Q38335697-14D693D1-77C7-4DD6-8FB1-CBFD10E91832

Q38335697-1C5CA3C1-76EE-4A56-B94D-6F4862623BEE

Q38335697-25F848FE-E2FF-4F4D-A02D-27341BEDA2D3

P304

Q38335697-D2335610-28C8-4691-831D-C0DE0F8C1363

P31

Q38335697-CA175404-BB74-4BBB-BA0C-FA4D1693AF98

P356

Q38335697-21BE09E1-C288-4C53-BDF8-3336F283EA41

P433

Q38335697-8D787FD0-7420-4D94-AF10-1EF0DC04D9BE

P478

Q38335697-E5024FB8-14B3-4C97-BF66-6FB3BC95BADF

P577

Q38335697-4106924D-88E8-42E5-A1FD-915EDE2BEB1E

P5875

Q38335697-8FE7A78F-0639-42BD-9B0F-D90A3427D177

P698

Q38335697-23058F0C-FA20-4D03-A790-F36175223D63

P921

Q38335697-CEE58F34-DB33-45E9-9BA5-CE41750F7AC4

P932

Q38335697-D247B417-A196-4004-BC86-301648DC1B08

P356

P1433

International Journal of Oncology

P1476

Histone deacetylase inhibitors ...... ositive prostate cancer cells.

@en

P2093

E Shyam P Reddy

http://www.w3.org/2001/XMLSchema#string

Ganapathy K Bhat

http://www.w3.org/2001/XMLSchema#string

Huali Xu

http://www.w3.org/2001/XMLSchema#string

Roland Matthews

http://www.w3.org/2001/XMLSchema#string

Shubhalaxmi Kayarthodi

http://www.w3.org/2001/XMLSchema#string

Veena N Rao

http://www.w3.org/2001/XMLSchema#string

Wendell S Fortson

http://www.w3.org/2001/XMLSchema#string

William E Grizzle

http://www.w3.org/2001/XMLSchema#string

Yasuo Fujimura

http://www.w3.org/2001/XMLSchema#string

P2860

The erg gene: a human gene related to the ets oncogene

Binding and modulation of p53 by p300/CBP coactivators

The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein

The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains

An ERG (ets-related gene)-associated histone methyltransferase interacts with histone deacetylases 1/2 and transcription co-repressors mSin3A/B

ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex

Critical role for a single leucine residue in leukemia induction by E2A-PBX1

The Ews-ERG fusion protein can initiate neoplasia from lineage-committed haematopoietic cells.

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

P304

111-119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/IJO.2011.1014

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51076728

http://www.w3.org/2001/XMLSchema#string

P698

21519790

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

3329756

http://www.w3.org/2001/XMLSchema#string